サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1537002

膵・胆管結石管理市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年

Pancreatic And Bile Duct Stone Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 202 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
膵・胆管結石管理市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年
出版日: 2024年08月14日
発行: Persistence Market Research
ページ情報: 英文 202 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の膵・胆管結石管理市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主要な洞察

  • 膵・胆管結石管理市場規模（2024E）：13億米ドル
  • 市場予測値（2033F）：19億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：4.7%

膵・胆管結石管理市場- 調査範囲

膵・胆管結石管理市場には、膵・胆管結石の診断、管理、治療を目的とした様々な医療処置や医療機器が含まれます。この市場は、病院、専門クリニック、外科センターを対象としており、内視鏡的逆行性胆管膵管造影（ERCP）、経皮的アプローチ、高度な手術器具を含む様々なソリューションを提供しています。市場成長の原動力は、膵臓結石および胆管結石の有病率の増加、低侵襲技術の進歩、効果的な管理オプションに関する意識の高まりです。

市場成長の促進要因：

いくつかの要因が膵・胆管結石管理市場の成長を促進しています。高脂肪食や肥満などのライフスタイル要因による膵・胆管結石の発生率の増加は、重要な促進要因です。強化されたERCP技術や革新的な結石回収装置など、低侵襲手技の技術的進歩が成長に寄与しています。さらに、新興国におけるヘルスケア支出の増加と医療インフラの改善により、高度な治療オプションへのアクセスが拡大しています。

市場抑制要因：

有望な成長見通しとは裏腹に、同市場は高額な手技費用や専門知識の必要性などの課題に直面しています。特にヘルスケア予算が限られている発展途上地域では、高度な診断機器や治療機器のコストが高額になる可能性があります。さらに、手技が複雑なため熟練した専門家が必要となり、訓練された人材が不足している地域では市場の成長が制限される可能性があります。こうした課題に対処するには、技術をより安価に提供し、ヘルスケア専門家のトレーニングと教育を強化する努力が必要です。

市場機会：

膵・胆管結石管理市場は、技術革新、人口動向、進化する医療提供モデルによって大きな成長機会がもたらされます。高度な画像診断システムやロボット支援手術などの新技術の開発により、治療成績の向上と回復時間の短縮がもたらされます。外来診療所や在宅医療など、従来の環境以外にもこうした技術の応用が拡大することで、市場成長の新たな道が開かれます。戦略的パートナーシップ、研究開発への投資、費用対効果の高いソリューションのイントロダクションは、こうした機会を生かし、市場参入を強化するために不可欠です。

本レポートで扱う主な質問

  • 世界の膵・胆管結石管理市場の成長を促す主な要因は何か？
  • 膵・胆管結石管理において、どのような技術や手技が支持を集めているか？
  • 医療技術の進歩は市場の競合情勢をどのように変えているのか？
  • 市場に貢献している主要プレイヤーは誰で、市場での地位を維持するためにどのような戦略をとっているのか？
  • 世界の膵・胆管結石管理市場の新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 製品率/使用状況分析
  • 外科手術件数
  • 新製品の発売と承認
  • 主な規制- 地域別
  • PESTEL分析
  • ポーターの分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • 適応症別
    • エンドユーザー別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界市場の需要（金額）分析

  • 市場金額分析、2019～2023年
  • 市場金額予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第8章 製品別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場金額分析、2019～2023年
  • 市場金額予測、2024～2033年
    • 電気油圧式/レーザー結石破砕術
  • 製品別市場の魅力分析

第9章 適応症別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場金額分析、2019～2023年
  • 市場金額予測、2024～2033年
    • 膵石
    • 胆管結石
  • 適応症別市場の魅力分析

第10章 エンドユーザー別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場金額分析、2019～2023年
  • 市場金額予測、2024～2033年
    • 病院
    • 外来手術センター
    • 専門クリニック
  • エンドユーザー別市場の魅力分析

第11章 地域別：世界市場分析

  • イントロダクション
  • 市場金額分析、2019～2023年
  • 市場金額予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第12章 北米市場分析

第13章 ラテンアメリカ市場分析

第14章 欧州市場分析

第15章 東アジア市場分析

第16章 南アジア市場分析

第17章 オセアニア市場

第18章 中東・アフリカ（中東・アフリカ）市場分析

第19章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場集中
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 主要プレーヤーによるブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • Boston Scientific Corporation
    • Argon Medical Devices
    • Olympus Endoscopy
    • Cook Medical
    • Medtronic Inc.
    • Conmed Endoscopic Technologies
    • CR BARD Inc（Becton, Dickinson and Company）
    • Cordis（Cardinal Health Inc.）
    • Zeon Medical Co., Ltd.
    • Medi-Globe（ENDO-Flex）GmbH
    • Taewoong Medical Co., Ltd.
    • Q3 Medical Devices

第21章 使用される前提条件と頭字語

第22章 調査手法

目次
Product Code: PMRREP31379

Persistence Market Research has recently released a comprehensive report on the global pancreatic and bile duct stone management market. This report provides a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, and delivers detailed insights into the market structure.

Key Insights:

  • Pancreatic and Bile Duct Stone Management Market Size (2024E): USD 1.3 Billion
  • Projected Market Value (2033F): USD 1.9 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 4.7%

Pancreatic and Bile Duct Stone Management Market - Report Scope:

The pancreatic and bile duct stone management market involves a range of medical procedures and devices designed to diagnose, manage, and treat stones in the pancreatic and bile ducts. This market caters to hospitals, specialized clinics, and surgical centers, offering various solutions including endoscopic retrograde cholangiopancreatography (ERCP), percutaneous approaches, and advanced surgical instruments. The market growth is driven by increasing prevalence of pancreatic and bile duct stones, advancements in minimally invasive technologies, and rising awareness about effective management options.

Market Growth Drivers:

Several factors are propelling the growth of the pancreatic and bile duct stone management market. The increasing incidence of pancreatic and bile duct stones due to lifestyle factors, such as high-fat diets and obesity, is a significant driver. Technological advancements in minimally invasive procedures, such as enhanced ERCP techniques and innovative stone retrieval devices, contribute to the growth. Additionally, rising healthcare expenditure and improving healthcare infrastructure in emerging economies are expanding the accessibility of advanced treatment options.

Market Restraints:

Despite the promising growth prospects, the market faces challenges including high procedural costs and the need for specialized expertise. The cost of advanced diagnostic and treatment equipment can be prohibitive, especially in developing regions with limited healthcare budgets. Additionally, the complexity of the procedures requires skilled professionals, which may limit market growth in areas with a shortage of trained personnel. Addressing these challenges requires efforts to make technologies more affordable and increase training and education for healthcare professionals.

Market Opportunities:

The pancreatic and bile duct stone management market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of new technologies, such as advanced imaging systems and robotic-assisted surgery, offers improved treatment outcomes and reduced recovery times. Expanding applications of these technologies beyond traditional settings, such as in outpatient clinics and homecare, open new avenues for market growth. Strategic partnerships, investment in R&D, and the introduction of cost-effective solutions are essential to capitalize on these opportunities and enhance market reach.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the pancreatic and bile duct stone management market globally?
  • Which technologies and procedures are gaining traction in the management of pancreatic and bile duct stones?
  • How are advancements in medical technology reshaping the competitive landscape of the market?
  • Who are the key players contributing to the market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global pancreatic and bile duct stone management market?

Competitive Intelligence and Business Strategy:

Leading players in the pancreatic and bile duct stone management market, including Medtronic plc, Boston Scientific Corporation, and Olympus Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced devices and procedures for effective stone management. Collaborations with healthcare providers, surgical centers, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research and evidence-based practices helps enhance patient outcomes and drive market growth.

Key Companies Profiled:

  • Boston Scientific Corporation
  • Argon Medical Devices
  • Olympus Endoscopy
  • Cook Medical
  • Medtronic Inc.
  • Conmed Endoscopic Technologies
  • CR BARD Inc (Becton, Dickinson and Company)
  • Cordis (Cardinal Health Inc.)
  • Zeon Medical Co., Ltd.
  • Medi-Globe (ENDO-Flex) GmbH
  • Taewoong Medical Co., Ltd.
  • Q3 Medical Devices

Key Segments Covered in Pancreatic and Bile Duct Stone Management Industry Research

Product:

  • ERCP Catheters
  • Guidewire
  • Sphincterotome
  • Dilation Balloon Catheters
  • Extraction Balloon Catheters
  • Extraction Basket Catheters
  • Biliary Stents
  • Self-Expandable Biliary Stents
  • Dilation Large-Balloon Catheters
  • Mechanical Lithotripsy
  • Electrohydraulic/Laser Lithotripsy

Indication:

  • Pancreatic Stones
  • Bile Duct Stones

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Rate/Usage Analysis
  • 4.2. Surgical Procedure Volume
  • 4.3. New Product Launch & Approval
  • 4.4. Key Regulations - By Region
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Catheter, Stent and Guidewire Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Prevalence of Pancreatic Stones
    • 5.2.2. Rising Prevalence of Bile Duct Stones
    • 5.2.3. Technology Advancement
    • 5.2.4. Innovation and Development
    • 5.2.5. Regulatory Approvals
    • 5.2.6. Adoption Rate
    • 5.2.7. Number of Procedures Performed
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Indication
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2033
    • 8.3.1. Electrohydraulic/Laser Lithotripsy
  • 8.4. Market Attractiveness Analysis, By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2033
    • 9.3.1. Pancreatic Stones
    • 9.3.2. Bile Duct Stones
  • 9.4. Market Attractiveness Analysis, By Indication

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Ambulatory Surgical Centers
    • 10.3.3. Speciality Clinics
  • 10.4. Market Attractiveness Analysis, By End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Indication
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Indication
        • 12.8.1.2.3. By End User
    • 12.8.2. Canada Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Indication
        • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Indication
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Indication
        • 13.8.1.2.3. By End User
    • 13.8.2. Brazil Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Indication
        • 13.8.2.2.3. By End User
    • 13.8.3. Argentina Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Indication
        • 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By End User
    • 14.8.2. Italy Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By End User
    • 14.8.3. France Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Indication
        • 14.8.3.2.3. By End User
    • 14.8.4. U.K. Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.4.2.1. By Product
        • 14.8.4.2.2. By Indication
        • 14.8.4.2.3. By End User
    • 14.8.5. Spain Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.5.2.1. By Product
        • 14.8.5.2.2. By Indication
        • 14.8.5.2.3. By End User
    • 14.8.6. BENELUX Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.6.2.1. By Product
        • 14.8.6.2.2. By Indication
        • 14.8.6.2.3. By End User
    • 14.8.7. Russia Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.7.2.1. By Product
        • 14.8.7.2.2. By Indication
        • 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market End User (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product
    • 15.4.2. By Indication
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By End User
    • 15.8.2. Japan Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By End User
    • 15.8.3. South Korea Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By End User
    • 16.8.2. Indonesia Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By End User
    • 16.8.3. Malaysia Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By End User
    • 16.8.4. Thailand Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By End User
    • 17.8.2. New Zealand Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Indication
    • 18.4.3. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By End User
    • 18.8.2. Turkiye Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By End User
    • 18.8.3. South Africa Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By End User
    • 18.8.4. North Africa Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Indication
        • 18.8.4.2.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Concentration
  • 19.4. Market Presence Analysis
    • 19.4.1. By Regional Footprints of Players
    • 19.4.2. By Product Footprints of Players
    • 19.4.3. By Channel Footprints of Players

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Branding and Promotional Strategies, By Key Players
  • 20.3. Key Development Analysis
  • 20.4. Competition Deep Dive
    • 20.4.1. Boston Scientific Corporation
      • 20.4.1.1. Overview
      • 20.4.1.2. Product Portfolio
      • 20.4.1.3. Sales Footprint
      • 20.4.1.4. Key Financials
      • 20.4.1.5. SWOT Analysis
      • 20.4.1.6. Strategy Overview
        • 20.4.1.6.1. Marketing Strategy
        • 20.4.1.6.2. Product Strategy
        • 20.4.1.6.3. Channel Strategy
    • 20.4.2. Argon Medical Devices
      • 20.4.2.1. Overview
      • 20.4.2.2. Product Portfolio
      • 20.4.2.3. Sales Footprint
      • 20.4.2.4. Key Financials
      • 20.4.2.5. SWOT Analysis
      • 20.4.2.6. Strategy Overview
        • 20.4.2.6.1. Marketing Strategy
        • 20.4.2.6.2. Product Strategy
        • 20.4.2.6.3. Channel Strategy
    • 20.4.3. Olympus Endoscopy
      • 20.4.3.1. Overview
      • 20.4.3.2. Product Portfolio
      • 20.4.3.3. Sales Footprint
      • 20.4.3.4. Key Financials
      • 20.4.3.5. SWOT Analysis
      • 20.4.3.6. Strategy Overview
        • 20.4.3.6.1. Marketing Strategy
        • 20.4.3.6.2. Product Strategy
        • 20.4.3.6.3. Channel Strategy
    • 20.4.4. Cook Medical
      • 20.4.4.1. Overview
      • 20.4.4.2. Product Portfolio
      • 20.4.4.3. Sales Footprint
      • 20.4.4.4. Key Financials
      • 20.4.4.5. SWOT Analysis
      • 20.4.4.6. Strategy Overview
        • 20.4.4.6.1. Marketing Strategy
        • 20.4.4.6.2. Product Strategy
        • 20.4.4.6.3. Channel Strategy
    • 20.4.5. Medtronic Inc.
      • 20.4.5.1. Overview
      • 20.4.5.2. Product Portfolio
      • 20.4.5.3. Sales Footprint
      • 20.4.5.4. Key Financials
      • 20.4.5.5. SWOT Analysis
      • 20.4.5.6. Strategy Overview
        • 20.4.5.6.1. Marketing Strategy
        • 20.4.5.6.2. Product Strategy
        • 20.4.5.6.3. Channel Strategy
    • 20.4.6. Conmed Endoscopic Technologies
      • 20.4.6.1. Overview
      • 20.4.6.2. Product Portfolio
      • 20.4.6.3. Sales Footprint
      • 20.4.6.4. Key Financials
      • 20.4.6.5. SWOT Analysis
      • 20.4.6.6. Strategy Overview
        • 20.4.6.6.1. Marketing Strategy
        • 20.4.6.6.2. Product Strategy
        • 20.4.6.6.3. Channel Strategy
    • 20.4.7. CR BARD Inc (Becton, Dickinson and Company)
      • 20.4.7.1. Overview
      • 20.4.7.2. Product Portfolio
      • 20.4.7.3. Sales Footprint
      • 20.4.7.4. Key Financials
      • 20.4.7.5. SWOT Analysis
      • 20.4.7.6. Strategy Overview
        • 20.4.7.6.1. Marketing Strategy
        • 20.4.7.6.2. Product Strategy
        • 20.4.7.6.3. Channel Strategy
    • 20.4.8. Cordis (Cardinal Health Inc.)
      • 20.4.8.1. Overview
      • 20.4.8.2. Product Portfolio
      • 20.4.8.3. Sales Footprint
      • 20.4.8.4. Key Financials
      • 20.4.8.5. SWOT Analysis
      • 20.4.8.6. Strategy Overview
        • 20.4.8.6.1. Marketing Strategy
        • 20.4.8.6.2. Product Strategy
        • 20.4.8.6.3. Channel Strategy
    • 20.4.9. Zeon Medical Co., Ltd.
      • 20.4.9.1. Overview
      • 20.4.9.2. Product Portfolio
      • 20.4.9.3. Sales Footprint
      • 20.4.9.4. Key Financials
      • 20.4.9.5. SWOT Analysis
      • 20.4.9.6. Strategy Overview
        • 20.4.9.6.1. Marketing Strategy
        • 20.4.9.6.2. Product Strategy
        • 20.4.9.6.3. Channel Strategy
    • 20.4.10. Medi-Globe (ENDO-Flex) GmbH
      • 20.4.10.1. Overview
      • 20.4.10.2. Product Portfolio
      • 20.4.10.3. Sales Footprint
      • 20.4.10.4. Key Financials
      • 20.4.10.5. SWOT Analysis
      • 20.4.10.6. Strategy Overview
        • 20.4.10.6.1. Marketing Strategy
        • 20.4.10.6.2. Product Strategy
        • 20.4.10.6.3. Channel Strategy
    • 20.4.11. Taewoong Medical Co., Ltd.
      • 20.4.11.1. Overview
      • 20.4.11.2. Product Portfolio
      • 20.4.11.3. Sales Footprint
      • 20.4.11.4. Key Financials
      • 20.4.11.5. SWOT Analysis
      • 20.4.11.6. Strategy Overview
        • 20.4.11.6.1. Marketing Strategy
        • 20.4.11.6.2. Product Strategy
        • 20.4.11.6.3. Channel Strategy
    • 20.4.12. Q3 Medical Devices
      • 20.4.12.1. Overview
      • 20.4.12.2. Product Portfolio
      • 20.4.12.3. Sales Footprint
      • 20.4.12.4. Key Financials
      • 20.4.12.5. SWOT Analysis
      • 20.4.12.6. Strategy Overview
        • 20.4.12.6.1. Marketing Strategy
        • 20.4.12.6.2. Product Strategy
        • 20.4.12.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology